All News

January 04. 2010.

The Big Reset

Thank you

Waters Video Showcase is accessible at waters.com/customers and is the largest such assemblage of expert testimonials in the industry.

December 18, 2009.

December 17, 2009.

Sanofi-Aventis is recalling hundreds of thousands of doses of the childrens' version of its H1N1 vaccine. Conspiracy theorists are going to have a field day.

Transparency can be a double-edged sword - especially if you are a doctor receiving money to speak on behalf of a drug company. Sure the pay day is nice, but does the public outing open you up to scrutiny?

It's been a tough week for clinical trials: One drug got canned and another was re-tuned in the wake of failed end points and patient deaths.

PharmRep Editorial Calendar

11 December.

Painkiller abuse has become so prevalent that FDA is working with pharma to create a strategy for handling misuse of all drugs across the entire opioid category.

Drug manufacturers came under fire at a hearing of the House Energy and Commerce?s health subcommittee for bumping drug prices 10 percent this year. Pharma claims rumors that it?s boosting costs in anticipation of healthcare reform are baseless, but the industry could be facing an uphill battle.

Reid Paul, Editor-in-Chief of Pharmaceutical Representative Magazine joins host George Koroneos to discuss the top five pharmaceutical industry news stories of the week

With the fourth quarter quickly coming to a close, talks of job cuts are once again in the air. The first major layoffs could be coming at Sanofi-Aventis, which is rumored to be slashing up to 1,500 positions.

A new study of industry tax professionals conducted by PricewaterhouseCoopers predicts higher taxes for Big Pharma in the wake of the global economic downturn. What can your company do to remain competitive and discover new incentives?

As the old orthodoxy shatters, pharma must stand firm or leave the field.

Our sixth annual pipeline report details 44 drugs that industry will be talking about in 2010.

The fight against cancer may be the litmus test for how regulation and private investment work together to address the disease burden.

December 01

01 December

Feds targeted 136 Web sites offering foreign or unapproved drugs as part of International Internet Week of Action. But does the FDA campaign ignore a larger crisis endangering consumers?

Life Technologies improves e-commerce infrastructure with the help of Infosys

Allosteric modulators are an emerging class of orally available small molecule drugs that may have multiple advantages compared to traditional drugs.

standard terms and conditions

standard terms and conditions

Following through with its promise to waste no time in merging Wyeth and Pfizer, the pharma giant announced restructuring plans for its global research network.

Developing countries will receive the scarce vaccine for free, as GSK remains confident it will fulfill contractual vaccine obligations around the world.